NOVEL PEPTIDE HAVING ANALGESIC ACTION AND ITS PREPARATION

NEW MATERIAL:A peptide shown by the formula (amino acid residue other than D-amino acid shows L-amino acid residue). USE:An analgesic. Since this peptide is linked to a receptor which is different from a mureceptor to which morphine is bonded and it shows analgesic action, it has no indulgence. PREP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ARAKAWA YOSHIHIRO, IKEDA MASUHIRO, KANEKO TAKETOSHI, TACHIBANA SHINROU, YAMATSU KIYOMI, NAKAZAWA TAKAHIRO, OOYA SHIZUKO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:NEW MATERIAL:A peptide shown by the formula (amino acid residue other than D-amino acid shows L-amino acid residue). USE:An analgesic. Since this peptide is linked to a receptor which is different from a mureceptor to which morphine is bonded and it shows analgesic action, it has no indulgence. PREPARATION:The titled peptide can be synthesized by solid-phase or liquid- phase method. When it is synthesized by solid-phase method, Gln having a protected N end is linked to a styrenic resin carrier by amide bond, the protecting group is removed, the resultant compound is condensed with Asn whose N end is previously protected with BOC to form a peptide bond. The amino acid whose N end and functional group at the side chain protected optionally in this way is condensed in the order of amino acid arrangement shown by the formula, to give a protected peptide shown by the formula, which is treated with hydrogen fluoride so that the protecting group and the resin are removed from it, to give the peptide shown by the formula.